Westfield Capital Management
RNAM

Westfield Capital Management’s Avidity Biosciences RNAM Stock Holding History

Westfield Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-471,127
Closed -$34M – 279
2025
Q4 		$34M Buy
+471,127
New +$30.4M 0.14% 168
2020
Q4 		– Sell
-9,200
Closed -$259K – 263
2020
Q3 		$259K Buy
+9,200
New +$266K ﹤0.01% 234

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Westfield Capital Management's RNAM Position: Q1 2026 in Review

Westfield Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 471,127 shares — an estimated $34M sold.

Westfield Capital Management first reported a position in RNAM in Q3 2020 and held it in 2 quarters. The position peaked at $34M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Westfield Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Westfield Capital Management sold 471,127 Avidity Biosciences shares in Q1 2026, an estimated $34M.
  • Westfield Capital Management first reported a position in Avidity Biosciences in Q3 2020 and held it in 2 quarters.
  • Westfield Capital Management's Avidity Biosciences position peaked at $34M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.